Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT04106908

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

Conditions: VWD - Von Willebrand's Disease

Sex: All

Ages: 6 Years – N/A

Enrollment: 38

Sponsor: Octapharma

Location: Caen Study Site Caen

Summary

MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study

Eligibility Criteria

Inclusion Criteria: The study will involve patients (≥ 6 years of age) from the participating centres treated with Eqwilate® (either on-demand, as perioperative prophylaxis, or as prophylaxis) during the time inclusion period will be opened. Patients will be of any VWD type, previously treated or untreated. Exclusion Criteria: * N/A

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04106908). StuddyBuddy aggregates publicly available trial information.